Precision medicine goes global: How collaboration can redesign healthcare

Precision medicine goes global: How collaboration can redesign healthcare

Publication date: Sep 10, 2019

Sharing health information to inform precision medicine initiatives is taking data sharing to a whole new level-and crossing international datelines.

Spurred on by value-based care payment models and the need to manage populations of patients, payers and providers have become more adept at sharing data within their own systems and with other organizations in their region.

The U. S. government has pushed to improve interoperability and allow for wider dissemination of genomic and other data through programs such as the Precision Medicine Initiative and Sync for Science for good reason: Developing optimal medical treatments and drugs holds great promise for improving population health.

-There’s going to be big data management and master data issue that arises from all this data [and] getting the data in the right place at the right time will be a challenge. “

-There’s a data fabric that has to get created in the ecosystem,” says Munzoor Shaikh, a director in the healthcare and life sciences practice at West Monroe.

Rather, he envisions domain-specific data hubs, including one focused on precision medicine.

The ARC Innovation Center was founded at Israel’s largest hospital, Sheba Medical Center in Ramat Gan-participants include Intermountain Healthcare in Utah, Stanford Healthcare in California and Ottawa Hospital in Canada.

ARC, which stands for accelerate, redesign and collaborate and includes both a virtual and physical workspace, focuses on using AI, big data and genomics to drive precision medicine initiatives.

One of the reasons healthcare hasn’t realized the full potential of precision medicine is that it has focused too much on genomics, Zimlichman contends.

ARC uses a cloud platform called MDClone, which creates -synthetic data” from original data sets.

-Now we are able to take all of our malignant melanoma patients from Sheba, all of the patients from Intermountain and all of the patients from Ottawa and join them together into one source of data,” Zimlichman says.

Going beyond borders Canada’s Ottawa Hospital, a 1,200-bed academic health science center, participates in the ARC initiative with an eye toward providing high-quality care to its patients and better understanding the population it serves.

-Even though we have a lot of data and we’ve helped make it accessible, we don’t even have all the data for the population of patients we look after,” says Alan J. Forster, MD, the organization’s vice president of innovation and quality -People talk about big data, but we’re not really a big data shop right now because we don’t have all of the possible data that you could have of people that could tell you a story about their health. “

Bigger data sample sizes helps, too, in a district that includes just about 1. 3 million people.

Data data-sharing -unlocks our ability to understand the impact of our drugs, it helps us understand the value created from some of our procedures.

Concepts Keywords
AI Artificial intelligence
ARCA Genomics
Big Data Systems science
Blockchain Precision medicine
California Computing
Canada Transaction processing
Care System Technology forecasting
Cloud Big data
Depression Data management
District Insurance agents
Ecosystem Long healthcare
Europe Healthcare practice
Fabric Reasons healthcare hasnt
Genomics
Globe
Healthcare
Hospital
Insurance
Intermountain Healthcare
Interoperability
Israel
Malignant Melanoma
Metabolomic
Ottawa
Population Health
Precision Medicine
Privacy
Proteomic
Sheba
Spectrum
Stanford
The Move
Utah
Wearables
West Monroe

Semantics

Type Source Name
drug DRUGBANK Icodextrin
gene UNIPROT IMPACT
gene UNIPROT AICDA
gene UNIPROT ARSK
gene UNIPROT DBF4
drug DRUGBANK Tropicamide
disease DOID malignant melanoma
disease MESH malignant melanoma
gene UNIPROT DNMT1
gene UNIPROT CD69
disease MESH depression
gene UNIPROT GAN
gene UNIPROT ARC
gene UNIPROT NOL3
drug DRUGBANK 3 7 11 15-Tetramethyl-Hexadecan-1-Ol
disease MESH ARC
gene UNIPROT ELAVL2
drug DRUGBANK Huperzine B
gene UNIPROT SIRPA
drug DRUGBANK Nonoxynol-9
gene UNIPROT GPI
disease MESH privacy
gene UNIPROT RXFP2
gene UNIPROT SYNC

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *